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Abstract
Synaptotagmins are known to mediate diverse forms of Ca
2+-triggered exocytosis through their C2 domains, but the
principles underlying functional differentiation among them are unclear. Synaptotagmin-1 functions as a Ca
2+ sensor in
neurotransmitter release at central nervous system synapses, but synaptotagmin-7 does not, and yet both isoforms act as
Ca
2+ sensors in chromaffin cells. To shed light into this apparent paradox, we have performed rescue experiments in
neurons from synaptotagmin-1 knockout mice using a chimera that contains the synaptotagmin-1 sequence with its C2B
domain replaced by the synaptotagmin-7 C2B domain (Syt1/7). Rescue was not achieved either with the WT Syt1/7 chimera
or with nine mutants where residues that are distinct in synaptotagmin-7 were restored to those present in synaptotagmin-
1. To investigate whether these results arise because of unique conformational features of the synaptotagmin-7 C2B
domain, we determined its crystal structure at 1.44 A ˚ resolution. The synaptotagmin-7 C2B domain structure is very similar
to that of the synaptotagmin-1 C2B domain and contains three Ca
2+-binding sites. Two of the Ca
2+-binding sites of the
synaptotagmin-7 C2B domain are also present in the synaptotagmin-1 C2B domain and have analogous ligands to those
determined for the latter by NMR spectroscopy, suggesting that a discrepancy observed in a crystal structure of the
synaptotagmin-1 C2B domain arose from crystal contacts. Overall, our results suggest that functional differentiation in
synaptotagmins arises in part from subtle sequence changes that yield dramatic functional differences.
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Introduction
The release of hormones and neurotransmitters by Ca
2+-
triggered exocytosis mediates a wide variety of biological
processes, including for instance interneuronal communication
and the control of diverse cardiovascular functions. Exocytosis at
different types of secretory cells is governed by similar protein
machineries that are fine tuned for specific regulatory require-
ments [1–3]. Members from the synaptotagmin family form a
hierarchy of Ca
2+ sensors and are believed to underlie at least in
part the distinct Ca
2+ dependencies of different forms of regulated
secretion [4]. Thus, synaptotagmin-1 is the Ca
2+ sensor that
triggers fast neurotransmitter release at the hippocampus [5,6],
while fast release is triggered in other brain regions by this same
isoform or by the closely related synaptotagmins-2 or -9 [7,8]. In
contrast, insulin secretion in pancreatic b cells depends on
synaptotagmin-7 [9], and acrosomal exocytosis in sperm appears
to involve synaptotagmin-6 [10]. In PC12 cells, Ca
2+-dependent
secretion is mediated by synaptotagmins-1 and -9 [11], whereas
chromaffin cells use synaptotagmins-1 and –7 as Ca
2+ sensors [12].
Functional differentiation among synaptotagmins is expected to
arise primarily from differences in the properties of the two C2
domains that form most of their cytoplasmic regions (referred to as
C2A and C2B domains). In this context, the C2 domains of
synaptotagmin-1 have been the subjects of particularly extensive
study. Both domains form characteristic b-sandwich structures
that bind three or two Ca
2+ ions (C2Ao rC 2B, respectively)
through loops located at the top of the b-sandwich, and do not
PLoS ONE | www.plosone.org 1 September 2010 | Volume 5 | Issue 9 | e12544undergo substantial conformational changes upon Ca
2+ binding
[13–17]. While the structures of both domains are similar, the
synaptotagmin-1 C2B domain contains two a-helices that are not
present in the C2A domain; one of these helices (HA) is generally
found in C2 domains of tandem C2 domain-proteins [18], while
the other helix (HB) is predicted to be present in only
synaptotagmins-1, -2 and -8 [17]. Both C2 domains bind to
phospholipids in a Ca
2+-dependent manner through the Ca
2+-
binding loops at the top face [19,20], and changes in the apparent
Ca
2+ affinity of this activity lead to parallel changes in the Ca
2+
dependence of neurotransmitter release [5,6]. However, phospho-
lipid binding alone cannot explain the observation that Ca
2+
binding to the C2B domain is much more critical for release than
Ca
2+ binding to the C2A domain [21–24]. A potential explanation
for this finding was provided by the observation that the C2B
domain (but not the C2A domain) can bind to membranes through
the bottom face, which allows simultaneous binding to two closely
apposed membranes and suggests that synaptotagmin-1 may
trigger neurotransmitter release by bringing the synaptic vesicle
and plasma membranes together in a Ca
2+-dependent manner
[25,26]. This proposal has been supported by the finding that
mutation of two arginines at the bottom face of the C2B domain
practically abolishes synaptotagmin-1 function [27]. Moreover,
synaptotagmin-1 binds to the SNARE complex that forms part of
the core of the membrane fusion machinery that mediates release
[28,29], and this interaction is primarily mediated by the C2B
domain [30–32].
Based on the sequence similarities between the synaptotagmin-1
C2 domains and those from other synaptotagmin isoforms and
other C2 domain-containing proteins involved in membrane
traffic, it seems likely that many of these C2 domains share at
least some of the properties found in synaptotagmin-1 – see [33-
35] for review. However, the C2 domains of some of these proteins
lack a full complement of predicted Ca
2+ ligands and, as a
consequence, do not bind Ca
2+ or phospholipids; instead they act
as protein-protein interaction domains [e.g. the Munc13-1 C2A
domain [36,37]]. Moreover, even some C2 domains with high
sequence similarity with the synaptotagmin-1 C2 domains can
have dramatically different properties. For instance, the piccolo/
aczonin C2A domain exhibits a dramatic Ca
2+-dependent
conformational change [38], and the synaptotagmin-4 C2B
domain does not bind Ca
2+, despite having all the predicted
Ca
2+-binding ligands, because of conformational differences with
respect to the synaptotagmin-1 C2B domain in the Ca
2+-binding
region [39]. Hence, it is difficult to reliably predict the properties
of C2 domains based on sequence analyses alone, and the basis for
functional differences among synaptotagmins is poorly understood.
The relation between the functions of synaptotagmins-1 and-7 is
particularly fascinating, as data obtained in chromaffin cells [12]
suggest that these two isoforms play at least partially redundant
roles, and yet synaptotagmin-7 does not function as a Ca
2+ sensor
for synaptic vesicle exocytosis despite being enriched in synapses
[40]. These findings do not arise from difference in the SNAREs,
since the same SNARE isoforms mediate exocytosis in both
systems - see for instance [41,42]. Note also that synaptotagmin-7
cannot rescue fast neurotransmitter release in neurons of
synaptotagmin-1 knockout (KO) mice, unlike synaptotagmins-2 and
-9 [8].
In this paper, we describe attempts to shed light onto this
apparent paradox through a combination of functional and
structural studies. We find that a chimeric protein containing the
synaptotagmin-1 sequence, but with the C2B domain replaced by
the synaptotagmin-7 C2B domain, is also unable to rescue fast
neurotransmitter release in synaptotagmin-1 KO neurons. Even
extensive mutagenesis of this chimera to make the C2B domain
more similar to that of synaptotagmin-1 did not lead to rescue of
fast release. Furthermore, deletion of the HB helix in synapto-
tagmin-1 led to a gain of function, showing that the absence of this
helix in synaptotagmin-7 does not underlie its inability to rescue
fast release. We describe the crystal structure of the Ca
2+-bound
synaptotagmin-7 C2B domain at 1.44 A ˚ resolution, which is very
similar to that of the synaptotagmin-1 C2B domain. The
synaptotagmin-7 C2B domain structure also shows that this
domain binds three Ca
2+ ions and that coordination of two of
the Ca
2+ ions is analogous to that found previously in solution by
NMR spectroscopy for the synaptotagmin-1 C2B domain [17],
suggesting that differences in Ca
2+ coordination observed in a
crystal structure of the latter [43] are due to distortions caused by
crystal contacts. Overall, our data further support the importance
of the C2B domain for synaptotagmin-1 function. Although we
cannot completely rule out the possibility that the lack of rescue of
fast release by the Syt1/7 chimeras might be due to problems with
proper targeting to synaptic vesicles and/or protein folding, our
data suggest that the functional differences between the synapto-
tagmin-1 and –7 C2B domains do not arise from conformational
differences but rather from subtle alterations in biochemical
properties caused by multiple residue substitutions. These results
also illustrate how it is much more difficult to confer a specific
functional activity of a protein to a closely related isoform than to
disrupt this activity.
Results
Replacing the synaptotagmin-1 C2B domain with the
synaptotagmin-7 C2B domain abolishes rescue of
neurotransmitter release
To investigate the basis for functional differentiation between
synaptotagmins-1 and -7, we used a rescue approach with autaptic
hippocampal glutamatergic neurons from synaptotagmin-1 KO
mice. The approach is illustrated in Figures 1A,B, which show that
excitatory postsynaptic currents (EPSCs) evoked by action
potentials are drastically reduced in synaptotagmin-1 KO neurons
(KO) compared to neurons from wild-type (WT) mice, and that
normal EPSCs can be obtained upon rescue of the synaptotagmin-
1 KO neurons with lentiviral expression of WT synaptotagmin-1
(Syt1 WT). Since synaptotagmin-7 cannot rescue the function of
synaptotagmin-1 in neurons [8], and Ca
2+ binding to the C2B
domain is more critical than Ca
2+ binding to the C2A domain for
synaptotagmin-1 function [21–24], we investigated whether
replacement of the synaptotagmin-1 C2B domain with the
synaptotagmin-7 C2B domain allows or abolishes rescue. For this
purpose, we constructed a lentiviral vector expressing a chimeric
protein that contains most of the synaptotagmin-1 sequence, but
with the C2B domain replaced by the synaptotagmin-7 C2B
domain (Syt1/7 WT; see domain diagram in Figure 1C).
Immunocytochemistry showed that this chimeric protein exhibits
a normal synaptic localization, similar to that of WT synapto-
tagmin-1 (Fig. 1D). However, the Syt1/7 chimeric protein was
unable to rescue the impairment of fast neurotransmitter release
observed in synaptotagmin-1 KO neurons (Figures 1E,F).
These results confirmed the importance of the C2B domain for
synaptotagmin-1 function and led us to use the Syt1/7 chimera as
a benchmark to investigate which residues of the synaptotagmin-1
C2B domain are fundamental for its role in synchronous
neurotransmitter release, yielding crucial functional differences
with the synaptotagmin-7 C2B domain. Figure 2A shows a
sequence alignment of the C2B domains from various synapto-
tagmin isoforms that illustrates the high sequence similarities
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synaptotagmin-1 C2B domain [17] highlighting some of the
residues that are different in synaptotagmin-7. Comparing the
synaptotagmins-1 and -7 C2B domains, 48% of their residues are
identical, and many of the differences between them represent
conservative substitutions. Note that some of the positions
exhibiting differences are also distinct in synaptotagmins-2 and/
or -9, which can rescue release in synaptotagmin-1 KO neurons
[8]. Hence, these differences are unlikely to underlie the lack of
rescue by synaptotagmin-7 or the Syt1/7 chimera. It also seems
unlikely that such lack of rescue arises from sequence differences in
the Ca
2+-binding loops at the top of the C2B domain (loops 1–3,
see Figure 2B), since their sequences are highly similar in
synaptotagmins-1, -2, -7 and -9 (Figure 2A), and synaptotagmin-
7 is highly efficient in Ca
2+-dependent phospholipid binding,
which constitutes the primary activity of these loops [44,45]. Based
on these arguments, and considering that ionic interactions are
important for the biochemical properties of the synaptotagmin C2
domains [20,29], we attempted to recover synaptotagmin-1-like
function in the Syt1/7 chimera by focusing on differences between
the synaptotagmin-1 and -7 C2B domains involving charged
residues or loops that are substantially different in synaptotagmin-
7, compared to synaptotagmins-1, -2 and -9.
A summary of the mutants of the Syt1/7 chimera that we
generated is shown in Figure 2C, and Figure 2B shows the locations
of some of the mutated residues on the structure of the
synaptotagmin-1 C2B domain. In all these mutants, residues from
the synaptotagmin-7 C2B domain sequence present in the chimera
were replaced with the corresponding residues of synaptotagmin-1
to make the chimera more ‘synaptotagmin-1 like’. For instance, in
mutant #1, Q393 at the bottom of the synaptotagmin-7 C2B
domain was replaced with an arginine, since the corresponding
residue in synaptotagmin-1 is arginine (R399) and an R399Q
mutation strongly impairs synaptotagmin-1 function [27]. Other
point mutations involving charge differences included: R390, which
is close to Q393 at the bottom of the C2B domain and is asparagine
(N396) in synaptotagmin-1; A295, which is at the top of the C2B
domainand is lysine(K301)in synaptotagmin-1; and E318,whichis
in the middle of a characteristic polybasic region at the side of the
C2B domain and is lysine (K324) in synaptotagmin-1. We also
replaced two loops at the bottom of the C2B domain (residues 275–
284 and 343–350 of synaptotagmin-7, which correspond to residues
281–290 and 349–356, respectively, of synaptotagmin-1), as well as
the linker region between the C2A and C2B domains (residues 260–
267 of synaptotagmin-7, corresponding to residues 266–273 of
synaptotagmin-1) (Figure 2C). Immunocytochemistry revealed that
all mutants were correctly targeted to synapses (data not shown), as
observed for the WT Syt1/7 chimera (Fig. 1D). However, none of
these mutations, whether performed individually or in combination,
was able to endow the Syt1/7 chimera with the ability to rescue fast
Ca
2+-triggered neurotransmitter release in synaptotagmin-1 KO
neurons (Figures 1E,F). It is indeed remarkable that such ability was
not recovered at least in part even in mutant #9, since 30 residues
were restored back to those present in synaptotagmin-1 in this
mutant, and these residues involve the major obvious differences
between the sequences of the synaptotagmins-7 and -1 C2B
domains.
Inhibitory role of the HB helix in synaptotagmin-1
function
The structure of the rabphilin C2B domain showed that a major
structural difference between the C2A and C2B domains of
tandem C2 domain proteins is the presence of helix HA at the
bottom of the b-sandwich [18]. It was later shown that the
synaptotagmin-1 C2B domain contains an additional helix at the
C-terminus (helix HB) that is predicted to be present only in
synaptotagmins-1, -2 and -8 [17]. Indeed, it has been proposed
that this helix might be critical for synaptotagmin-1 function [46],
and the absence of helix HB in the synaptotagmin-7 C2B domain
could explain its inability to rescue release in synaptotagmin-1 KO
neurons. To test this hypothesis, we prepared a lentiviral vector
expressing a synaptotagmin-1 fragment lacking the HB helix (Syt1
delta HB, containing residues 1–409) and performed additional
rescue experiments in synaptotagmin-1 KO neurons. Western
blotting and immunocytochemistry showed that Syt1 delta HB is
expressed at similar levels as WT synaptotagmin-1 and properly
targets to presynaptic terminals in synaptotagmin-1 KO neurons
(Figure S1). Importantly, deletion of the HB helix leads to a
significant increase in the EPSC amplitude (Figures 3A,B).
Measurement of the readily-releasable pool (RRP) of vesicles
using hypertonic sucrose solution showed that vesicle priming is
not affected by deletion of the HB helix (Figure 3C). Hence, the
deletion leads to an increase in the vesicular release probability,
measured as the ratio between EPSC charge and the RRP size
(Figure 3D). To further test this conclusion, we compared the
responses obtained upon repetitive stimulation, and found that the
delta HB mutation leads to a significant decrease in the paired-
pulse ratio compared to WT synaptotagmin-1 (Figures 3E,F), as
expected for an increase in the release probability. Finally, we also
measured the dependence of the EPSC amplitude on the
extracellular Ca
2+ concentration and found that the HB delta
mutant exhibits a significant increase in the apparent Ca
2+
sensitivity of release (Figure 3G). Hence, these results show that the
HB helix plays an inhibitory role in release and that its deletion
leads to a gain of function, indicating that the absence of this helix
in synaptotagmin-7 cannot explain its inability to rescue
neurotransmitter release in synaptotagmin-1 KO neurons.
Figure 1. The synapotagmin-7 C2B domain cannot replace the synapotagmin-1 C2B domain to trigger Ca
2+-evoked fast
neurotransmitter release in hippocampal neurons. (A,B) Ca
2+-triggered fast neurotransmitter release in wild-type neurons (WT), synapotagmin-
1 knockout neurons (KO), and KO neurons rescued by WT synapotagmin-1 (Syt1 WT). (A) Exemplary traces showing the evoked EPSCs. The arrows
represent stimulations; artifacts and action potentials are blanked. (B) Bar graphs showing the summary data of EPSC amplitudes. Data are expressed
as mean 6 SEM. The numbers of neurons analyzed are shown above the bars. **, P,0.001 compared to WT or Syt1 WT, one-way analysis of variance.
(C) Schematic diagrams illustrating the domain structures of WT synapotagmin-1 (Syt1 WT) and a chimeric synapotagmin-1/7 (Syt1/7 WT) in which
the synapotagmin-1 C2B domain (residues 266–421) is replaced by the synapotagmin-7 C2B domain (residues 260–403). N, N terminus; T,
transmembrane domain; L, linker region; C, C terminus. (D) Exemplary confocal images showing the presynaptic localization of Syt1 WT and Syt1/7
WT in synapotagmin-1 KO neurons. Neurons were immunostained with antibodies against the N-terminal portion of the synaptotagmin-1 C2A
domain (green images), Vglut1 (magenta images), and EGFP (not shown). The merged images show the presence of synaptotagmin-1 WT and Syt1/7
WT in the presynaptic termini identified by Vglut1. Scale bars: 2 mm. (E,F) Ca
2+-triggered fast neurotransmitter release in synapotagmin-1 KO neurons
rescued by Syt1 WT or chimeric Syt1/7 variants. The details of the Syt1/7 chimeric constructs are shown in Figure 2C. (E) Exemplary traces showing the
evoked EPSCs. The arrows represent stimulations; artifacts and action potentials are blanked. (F) Bar graphs showing the summary data of EPSC
amplitudes. Data are expressed as mean 6 SEM. The numbers of neurons analyzed are shown above the bars. None of the chimeric Syt1/7 variants is
able to restore the diminished EPSC amplitude of synapotagmin-1 KO neurons (P,0.001 compared to Syt1 WT, one-way analysis of variance).
doi:10.1371/journal.pone.0012544.g001
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The crystal structure of the synaptotagmin-4 C2B domain
showed substantial conformational differences with respect to the
synaptotagmin-1 C2B domain; these differences were unexpected,
given the high similarities between their sequences, and explained
the lack of Ca
2+ binding to the synaptotagmin-4 C2B domain [39].
Hence, we hypothesized that the inactivity of the Syt1/7 chimera
and its diverse mutants in the rescue experiments with synapto-
tagmin-1 KO neurons (Figure 1) might arise from conformational
differences between the C2B domains of synaptotagmins-1 and -7.
To test this hypothesis, we performed crystallization screens with
the isolated synaptotagmin-7 C2B domain and were able to obtain
crystals in the presence of Ca
2+ that diffracted to 1.44 A ˚. The
structure of the synaptotagmin-7 C2B domain was determined by
Figure 2. Sequence differences between the C2B domains of synaptotagmins-1 and -7. (A) Sequence alignment of the C2B domains from
selected rat synaptotagmin isoforms illustrating the similarities and differences among them. The first residue number of each sequence in each line
is indicated in parenthesis. Conserved residues are color-coded: blue, b-strands; red, helix HA; yellow, top loops; green, bottom loops; black, Ca
2+
ligands. The positions of the three Ca
2+-binding loops (loops 1–3) are indicated. Residues that are identical in the C2B domains of synaptotagmins-1, -
2 and -9 (the three isoforms that can support fast neurotransmitter release in cortical synapses [8]), but are different in the C2B domain of
synaptotagmin-7, are indicated by a + sign if they were mutated in the Syt1/7 chimeras (see panel C), or by a * otherwise. The orange lines above the
synaptotagmin-7 C2B domain sequence indicate the positions of fragments in the linker or loop sequences that were replaced with those of
synaptotagmin-1 in the Syt1/7 chimeras (see panel C). (B) Ribbon diagram of the NMR structure of the synaptotagmin-1 C2B domain [17] illustrating
the positions of selected residues mutated in the Syt1/7 chimers (shown as red stick models). The corresponding residue names (in single letter
amino acid code) and numbers in synaptotagmin-1 are indicated above, and those in synaptotagmin-7 are indicated below. The bound Ca
2+ ions are
shown as yellow spheres. The positions of the Ca
2+-binding loops and the two helices (HA and HB) are indicated. (C) Summary of chimeric Syt1/7
mutants used in this study. As illustrated in Figure 1C, Syt1/7 WT is composed of residues 1–265 of synaptotagmin-1 and the WT C2B domain
(residues 260–403) of synaptotagmin-7. Each of the Syt1/7 mutants is composed of the same residues of synaptotagmin-1 (residues 1–265) and
synaptotagmin-7 (residues 260–403) (represented in blue in the diagrams), but with the indicated mutations (illustrated by the orange boxes in the
diagrams). The residue numbers of mutations are based on the respective WT synaptotagmins-1 and -7. In addition to point mutations, several
stretches of residues in the synaptotagmin-7 C2B domain were changed to the corresponding residues in the synaptotagmin-1 C2B domain. These
changes are listed as Syt7(residues)/Syt1(residues). For example, in Syt1/7 mutant #5, the synaptotagmin-7 residues 275–284 and 343–350 were
replaced by the synaptotagmin-1 residues 281–290 and 349–356, respectively.
doi:10.1371/journal.pone.0012544.g002
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tagmin-1 C2B domain [43] (PDB accession code 1TJM) to
generate a search model. The data collection and refinement
statistics are described in Table 1.
Figure 4A shows a ribbon diagram of the structure of the
synaptotagmin-7 C2B domain, which consists of the b-sandwich
characteristic of C2 domains and, as expected, includes the HA
helix but not the HB helix observed in the synaptotagmin-1 C2B
domain (see Figure 2B). Apart from this expected difference, the
structure of the synaptotagmin-7 C2B domain is very similar to the
crystal structure of the synaptotagmin-1 C2B domain [43]
(Figure 4B). This high similarity includes the side chains, even
for surface-exposed side chains that would be expected to have
some degree of flexibility (e.g. K320 and K321 of synaptotagmin-
7, corresponding to K327 and K328 of synaptotagmin-1,
respectively; see Figure 4C). The r.m.s. deviation between 713
common atoms of the synaptotagmins-7 and -1 C2B domain is
0.71 A ˚, which is comparable to differences observed between
structures of a given protein in different crystal forms. Hence, the
differences between the conformations of the synaptotagmins-7
and -1 C2B domains can be considered to be within experimental
error.
Comparison of the crystal structure of the synaptotagmin-7 C2B
domain described here with the NMR structure of the synapto-
tagmin-1 C2B domain [17] leads to analogous conclusions to those
drawn when we used the X-ray structure of the latter for the
comparison. A backbone superposition of the three structures
(Figure 4D) did suggest that slight differences between the
conformations of Ca
2+-binding loops 1 and 3 in the synaptotag-
min-7 C2B domain (blue) and the synaptotagmin-1 C2B domain
structures obtained by X-ray (orange) or NMR (yellow) might be
meaningful, since the conformations of these loops in the two
synaptotagmin-1 C2B domain structures are clearly more similar
to each other than to their conformations in the synaptotagmin-7
C2B domain. However, loops 1 and 3 are known to have some
degree of flexibility in C2 domains due to their exposed nature,
and they are involved in extensive crystal contacts for the
synaptotagmin-7 C2B domain (Figure 4E). Hence, the slight
differences in the conformations of these loops are likely to arise
from the crystal contacts, and it seems highly unlikely that they
underlie the dramatic functional differences observed between
synaptotagmins-1 and -7.
The synaptotagmin-7 C2B domain binds three Ca
2+ ions
The presence of Ca
2+ in the conditions used to crystallize the
synaptotagmin-7 C2B domain allowed us to determine its Ca
2+-
binding mode and to compare it with those determined previously
for synaptotagmins-1 and -3. We observed three Ca
2+ ions bound
Figure 3. Helix HB plays an inhibitory role in fast Ca
2+-triggered neurotransmitter release. Hippocampal synaptotagmin-1 KO neurons
were rescued with WT or delta HB mutant synaptotagmin-1. (A,B) Average traces (A) and summary data (B) of basal EPSCs evoked by action potentials
at 0.2 Hz. The arrows represent stimulations; artifacts and action potentials are blanked. (C) Readily releasable vesicle pool (RRP) size was estimated by
measuring the charge of the transient synaptic current induced by hypertonic sucrose solution. (D) Vesicular release probability (Pvr) was calculated
by the ratio of evoked EPSC charge and RRP size. (E) Average traces of 5 consecutive EPSCs evoked at 50 Hz. (F) Paired-pulse ratio was calculated by
the ratio of the second EPSC amplitude and the first EPSC amplitude, which were evoked at 50 Hz. (G) Apparent Ca
2+-sensitivity of evoked release.
EPSC amplitudes were normalized by the maximal response and plotted against external Ca
2+ concentrations ([Ca
2+]e). Data were fitted with standard
Hill equation to obtain dissociation constant (Kd). WT, Kd=0.9360.01 mM, delta HB, Kd=0.7460.01 mM (P,0.05). All data are expressed as mean 6
SEM. The numbers of neurons analyzed are shown above the bars. *, P,0.05; ***, P,0.0001 compared WT Syt1 (Student’s t-test for panels B, C, D, and
F; two-way analysis of variance for panel G).
doi:10.1371/journal.pone.0012544.g003
Synaptotagmins-1/7 SAR
PLoS ONE | www.plosone.org 6 September 2010 | Volume 5 | Issue 9 | e12544at the cup shape formed by the top loops of the synaptotagmin-7
C2B domain (loops 1–3, Figure 4A). We also observed a fourth
Ca
2+ ion bound outside of this region, but this site is not common
in C2 domains [33] and the Ca
2+ ion is coordinated by only three
protein ligands, suggesting that occupation of this site is due to the
high Ca
2+ concentration present in the crystallization conditions
(20 mM) and is not physiologically relevant.
The three Ca
2+ ions bound at the cavity formed by the top loops
are coordinated by five aspartate and one serine side chains, as
well as by three backbone carbonyl groups (Figure 5A; the Ca
2+-
binding sites are numbered 1–3 as is common for C2 domains
[33]). This binding mode is analogous to that observed for the
synaptotagmin-1 C2A domain [15,16]. In contrast, the C2B
domain of synaptotagmin-1 was found to bind only two Ca
2+ ions
[17,43] (Figures 5B–C) due to the absence of the serine side chain
in loop 3 that helps to coordinate the third Ca
2+ ion in the
synaptotagmin-1 C2A domain (S235) and the synaptotagmin-7
C2B domain (S362). Note that this serine residue of loop 3 is not
generally conserved in synaptotagmin C2B domains (Figure 2A)
and hence binding of the third Ca
2+ ion is an unusual feature of
the synaptotagmin-7 C2B domain compared to other isoforms.
Correspondingly, no Ca
2+ binding to this site of the C2B domain
was observed in the recently determined crystal structure of a
synaptotagmin-3 C2AB fragment [47] (Figure 5D). A third bound
Ca
2+ ion was found in this region (labeled 4 in Figure 5D), but this
ion is coordinated by only three protein ligands.
Implications for the Ca
2+-binding mode of the
synaptotagmin-1 C2B domain
Despite the difference involving the third Ca
2+-binding site, the
ligands involved in coordinating the Ca
2+ ions in sites 1 and 2 of
the synaptotagmin-7 C2B domain (Figure 5A; coordinating waters
not shown) are analogous to those determined to be involved in
Ca
2+-binding to the synaptotagmin-1 C2B domain in solution by
NMR spectroscopy [17] (Figure 5B). It is worth noting that a
crystal structure of the synaptotagmin-1 C2B domain [43]
concluded that one of the aspartate side chains (D371) does not
coordinate directly the Ca
2+ ion in site 2, since a water molecule
was inserted between this Ca
2+ ion and D371 (Figure 5C).
However, despite the high resolution of this crystal structure (1.04
A ˚), there was clear evidence for a potential distortion of the Ca
2+-
binding site by crystal contacts, since D371 interacts with a lysine
(K324) from a neighboring molecule in this structure (Figure 5C).
Hence, it seems most likely that the correct binding mode of the
synaptotagmin-1 C2B domain is that determined in solution by
NMR spectroscopy [17], which is now further supported by the
crystal structure of the synaptotagmin-7 C2B domain presented
here (see discussion).
Discussion
Ca
2+-dependent exocytosis is known to depend on diverse Ca
2+
sensors that most likely emerged to meet distinct regulatory
requirements for different types of cells and secretory processes. It
also seems clear that at least some of the Ca
2+ sensors belong to the
synaptotagmin family [4]. However, the basic principles underly-
ing functional differentiation among different synaptotagmin
isoforms are not well understood, which is particularly well
emphasized by the findings that synaptotagmins-1 and -7 both
function as Ca
2+ sensors in chromaffin cells [12], whereas
neurotransmitter release in central nervous system synapses is
triggered by synaptotagmin-1 but not by synaptotagmin-7 [5,40].
To shed light into these principles, in this work we combined
structural studies by X-ray crystallography with a rescue approach
using a Syt1/7 chimera that cannot rescue neurotransmitter
release in synaptotagmin-1 neurons, and attempted to endow the
chimera with rescue activity with mutations that make the
synaptotagmin-7 C2B domain more similar to the synaptotag-
min-1 C2B domain. Although we were unable to obtain rescue
activity, our results yield the crystal structure of the synaptotag-
min-7 C2B domain and a number of insights into structure-
function relationships in synaptotagmins.
First, our data confirm and extend previous results that revealed
the central importance of the C2B domain for synaptotagmin-1
function. In previous studies, disrupting Ca
2+ binding to
synaptotagmin-1 C2B domain was found to abolish neurotrans-
mitter release [21,22], whereas disrupting Ca
2+ binding to the C2A
domain had milder effects [23,24]. Moreover, mutating two
arginines at the bottom of the C2B domain (R398 and R399) also
abolished synaptotagmin-1 function, showing that not only the
top, Ca
2+-dependent face, but also the bottom, Ca
2+-independent
face of the C2B domain plays a key role in release [27]. Notably,
one of these two arginines (R399) is a glutamine in synaptotagmin-
7 (Q393) (see Figure 2), which suggested a simple explanation for
the lack of rescue of neurotransmitter release by the Syt1/7
chimera, but replacing this glutamine with arginine (Q393R
mutation) did not confer rescue to the chimera. Indeed, most of
the mutant chimeras that we designed (mutants 1–9; Figure 2C)
contain all the Ca
2+ ligands at the top loops and the two arginines
at the bottom face of the C2B domain, and yet they are unable to
rescue neurotransmitter release in synaptotagmin-1 KO neurons. It is
important to note that the inability of at least some of the Syt1/7
chimeras to rescue fast release might arise because of improper
protein targeting and/or folding. However, our immunocyto-
chemistry data show that the chimeras were targeted to synapses,
and previous results with different synaptotagmin-1/7 chimeras
showed that including the N-terminal sequence of synaptotagmin-
Table 1. Refinement Statistics for the crystal structure of the
synaptotagmin-7 C2B domain.
Data Collection
Space Group P212121
Cell Dimensions a, b, c (A ˚) 35.60, 44.89, 87.38
Wavelength (A ˚) 1.0148
Resolution Range (A ˚)5 0 21.44 (1.4621.44)
Rsym (%) 3.9 (39.7)
I/s 31.1 (2.6)
Completeness (%) 98.0 (91.0)
Redundancy 4.7 (4.0)
No. Reflections 25,581 (1,158)
Refinement
Resolution range (A ˚)2 6 . 6 21.44 (1.5021.44)
Rwork (%) 16.0 (19.3)
Rfree (%) 18.1 (24.0)
No. Atoms
Non-H Protein/Solvent/Ca
2+ 1,243/183/4
Average B-value (A ˚2) 14.3/28.0/12.0
RMS deviations
Bond Lengths (A ˚) 0.021
Bond Angles (u) 1.34
doi:10.1371/journal.pone.0012544.t001
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vesicles [48]. In fact, synaptotagmin-1 appears to be functional
even if it is targeted to the plasma membrane [46]. Moreover, it
seems highly unlikely that the point mutations we introduced in
the Syt1/7 chimera, or replacement of the linker region, might
cause folding problems because all these mutated residues are
surface exposed. Even the two loop replacements involved mostly
exposed residues and conservative substitutions of buried side
chains that are unlikely to severely destabilize the domain. Hence,
although we cannot completely rule out folding or targeting
problems for some of the chimeras, our data do suggest that the
Ca
2+-binding sites at the top face and the arginines at the bottom
face of the C2B domain are necessary but not sufficient for
synaptotagmin-1 like function.
A potential explanation for the inability of synaptotagmin-7 [8]
or the Syt1/7 chimera (Fig. 1) to rescue synaptic exocytosis was the
absence of helix HB in the C2B domain, which was recently
proposed to be important for synaptotagmin-1 function [46].
However, our data (Fig. 3) clearly show that this helix has an
inhibitory role in synaptotagmin-1. It is also noteworthy that
synaptotagmins-1 and -7 are both able to bind Ca
2+, phospholipids
and SNAREs [14,40,44,49], which are the primary biochemical
activities generally believed to underlie synaptotagmin function. It
might be argued that, since the polybasic region of the C2B
domain seems to be involved in SNARE binding [31,50] and the
synaptotagmin-7 C2B domain contains a Lys to Glu substitution in
this region (E318), perhaps this substitution leads to weaker
SNARE binding. However, no substantial differences between
synaptotagmins-1 and -7 in SNARE binding were observed in a
previous comparative study [44], and replacing Glu318 with Lys
did not enable rescue activity on the Syt1/7 chimera (mutants 6–9;
see Figures 1, 2C). Hence, these observations suggest that Ca
2+,
Figure 4. Crystal structure of the synaptotagmin-7 C2B domain. (A) Ribbon diagram of the crystal structure of the synaptotagmin-7 C2B
domain with the b-strands numbered from 1 to 8. The positions of helix HA and the Ca
2+-binding loops are indicated. Bound Ca
2+ ions are shown as
yellow spheres. The N- and C-termini are labeled. (B) Superposition of ribbon diagrams of the crystal structures of synaptotagmin-7 C2B domain (blue)
and the synaptotagmin-1 C2B domain [43] (PDB accession code 1UOW) (orange). The positions of a-helices HA and HB are indicated. (C) Stick models
of the same superposition shown in panel (B) focusing on a region containing b-strands 4 and 5 (labeled with the corresponding numbers). Carbon
atoms are colored in blue or orange for the C2B domains of synaptotagmin-7 and -1, respectively. Oxygen atoms are red and nitrogen atoms are blue
in both structures. Selected side chains from the synaptotagmin-7 C2B domain are labeled. (D) Superposition of backbone stick models of the crystal
structure of the synaptotagmin-7 C2B domain (blue), and the structures of the synaptotagmin-1 C2B domain determined by X-ray crystallography [43]
(orange) or NMR spectroscopy [17] (PDB accession code 1K5W) (yellow). (E) Backbone stick models illustrating the extensive crystal contacts involving
the Ca
2+-binding loops of the synaptotagmin-7 C2B domain. The central molecule is colored in blue, with the positions of loops 1 and 3 indicated.
Symmetry-related molecules within the crystal that contact the Ca
2+-binding loops of this molecule are shown in red. The observed contacts are a
result of crystal packing.
doi:10.1371/journal.pone.0012544.g004
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synaptotagmin-1 function. Clearly, further research will be
necessary to test this possibility. For instance, synaptotagmin-1
appears to bind to the SNAREs in diverse modes, including an
interaction with the syntaxin-1/SNAP-25 heterodimer that
promotes vesicle docking [42,51], but the exact nature of these
interactions and the corresponding differences between synapto-
tagmin isoforms remain unclear.
Although we were unable to achieve rescue of fast neurotrans-
mitter release in synaptotagmin-1 KO neurons with the Syt1/7
chimeras, our experiments with multiple mutants underscore how
difficult it is to confer a specific activity to a protein isoform even
when the starting point is a closely related isoform. Although this
conclusion might seem trivial, it has not been sufficiently
appreciated in the past to the best of our knowledge. Note that
no rescue was observed even when we restored 30 residues of the
chimera C2B domain back to those present in synaptotagmin-1
(mutant #9), since the resulting C2B domain is highly similar to
the synaptotagmin-1 C2B domain and contains all the residues
that have been identified so far to be critical for synaptotamin-1
function. Moreover, the crystal structure of the synaptotagmin-7
C2B domain described here shows that its backbone structure and
even the conformations of many side chains are very similar to
those of the synaptotagmin-1 C2B domain, suggesting that their
functional differences do not arise from distinct structural
properties. In contrast, the synaptotagmin-4 C2B domain was
indeed found to have marked conformational differences with
respect to the synaptotagmin-1 C2B domain that explained the
inability of the former to bind Ca
2+ [39]. Note that the
synaptotagmin-4 C2B domain has a full complement of Ca
2+
ligands (Figure 2), and that the C2B domains of synaptotagmins-1
and -4 have a similar degree of sequence identity (45%) to that
between the C2B domains of synaptotagmins-1 and -7 (48%). All
of these observations show that, although sequence analyses are
sometimes very useful to predict biochemical and functional
properties of proteins, such properties are often very difficult to
predict and rationalize from the sequences alone. It is tempting to
speculate that subtle sequence and/or structural distinctions
among isoforms might be key to dictate dramatic functional
differences.
The similarity between the crystal structure of the synaptotag-
min-7 C2B domain described here and that of the synaptotagmin-
1C 2B domain (Figure 4) illustrates how the structures of
homologous proteins can be conserved exquisitely well, even in
the side chain conformations. This high similarity shows that there
is no obvious structural reason for the inability of synaptotagmin-7
to functionally replace synaptotagmin-1. We did observe a
distinction between their C2B domains with respect to Ca
2+
binding, since the synaptotagmin-7 C2B domain binds one more
Ca
2+ ion than the synaptotagmin-1 C2B domain due to the
presence of a serine in loop 3 (Figure 5). The observation of this
third Ca
2+ binding site shows that there can be variability in the
Figure 5. Comparison of the Ca
2+-binding modes of the C2B domains of synaptotagmins-1, -3 and -7. (A) Ribbon diagram showing the
Ca
2+-binding mode of the synaptotagmin-7 C2B domain, with the Ca
2+ ligands shown as color-coded stick models (green, carbon; blue, nitrogen; red,
oxygen) and the bound Ca
2+ ions shown as yellow spheres. (B) Ribbon diagram showing the Ca
2+-binding mode of the synaptotagmin-1 C2B domain
determined by NMR spectroscopy [17] (PDB accession code 1K5W). (C) Ribbon diagram showing the Ca
2+-binding mode of the synaptotagmin-1 C2B
domain determined by X-ray crystallography [43] (PDB accession code 1UOW). (D) Ribbon diagram showing the Ca
2+-binding mode of the
synaptotagmin-3 C2B domain in the X-ray structure of a synaptotagmin-3 C2AB fragment bound to Ca
2+ [47] (PDB accession code 3HN8). The Ca
2+-
binding sites in the different structures are numbered from 1 to 4 according to the nomenclature of ref. [33], with the same numbers used for
homologous sites. The color coding in (B–D) is the same as in panel (A), except that in (C) a small portion of a stick model of a second C2B domain
molecule within the crystal is shown with carbon atoms colored in orange. The side chain of K324 in this region of the second C2B domain molecule
makes a salt bridge with D371 of the central molecule as a result of crystal packing. A water molecule that coordinates Ca
2+ ion 2 and serves as a
bridge with the D371 side chain is shown as a red sphere. Note also that the serine side chain in loop 3 of the synaptotagmin-7 C2B domain (S362
panel A) is not present in the synaptotagmins-1 and -3 C2B domains (see Figure 2A) and, as a result, Ca
2+ does not bind to site 3 (B,C).
doi:10.1371/journal.pone.0012544.g005
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2+-binding sites in Ca
2+-dependent synaptotagmins.
In principle, this distinction could provide a potential explanation
for the lack of rescue of fast neurotransmitter release by the Syt1/7
chimera. However, it seems more likely that binding of the third
Ca
2+ ion might lead to a gain of function rather than to a complete
loss of function.
Importantly, the ligands observed for the first two Ca
2+-binding
sites of the synaptotagmin-7 C2B domain are analogous to those
originally identified by NMR spectroscopy as the Ca
2+-ligands for
the synaptotagmin-1 C2B domain [17] (Figure 5B), supporting the
notion that this binding mode is indeed correct. While a high-
resolution (1.04 A ˚) crystal structure of the synaptotagmin-1 C2B
domain had suggested that one of the ligands (D371) does not
directly coordinate Ca
2+ [43], this side chain was involved in a
crystal contact (Figure 5C). Moreover, this conclusion seemed to
rely in part on the assumption that the NMR methodology used to
determine the original structure of the synaptotagmin-1 C2B
domain cannot determine Ca
2+-binding modes accurately [43].
However, the 1.04 A ˚ crystal structure itself provided strong
evidence for the overall high quality of the NMR structure, since
both structures were highly similar (1.0 A ˚ r.m.s. deviation for 996
common atoms) and only differed slightly in the conformations of
flexible loop regions, including the loop that contains D371 and is
involved in crystal contacts. Furthermore, the location of the D371
side chain in the NMR structure was dictated not only by the mere
assumption that this side chain coordinates Ca
2+, as implied in ref.
[43], but also by multiple restraints derived from nuclear
Overhauser enhancements [17]. Note also that the Ca
2+-binding
modes of both synaptotagmin-1 C2 domains determined with our
NMR methodology [15–17] have been corroborated by multiple
crystal structures of homologous C2 domains (e.g. refs. [47,52,53]
and Figures 5A,D), and that the side chain corresponding to D371
coordinates the Ca
2+ ion in site 2 in all determined structures of C2
domains that bind Ca
2+ at this site, with the exception of the 1.04
A ˚ crystal structure of the synaptotagmin-1 C2B domain. From all
these observations, it seems almost certain that the Ca
2+-binding
mode in the 1.04 A ˚ crystal structure was distorted via lattice
contact, and that D371 acts indeed as a direct Ca
2+ ligand in
synaptotagmin-1 in solution and in vivo.
Methods
Lentivirus constructs and production
A modified lentiviral vector [27,54] was used, in which a human
synapsin-1 promoter and a ubiquitin C promoter drive the expression
of synaptotagmin variants and the reporter, enhanced green
fluorescent protein (EGFP), respectively. The same vector without
synaptotagmin served as a control construct. The cDNA of
wildtype mouse synaptotagmin-1 was cloned into the lentiviral
vector and was used to generate synaptotagmin-1 delta HB mutant
by standard recombinant DNA techniques. The cDNAs of
wildtype rat synaptotagmin-1 and synaptotagmin-7 were used to
generate chimeric synapotagmin-1/7 variants, which were subse-
quently cloned into the lentiviral vector. Lentiviruses were
produced by co-transfecting HEK 293T cells with the lentiviral
vector and two helper vectors, pVSVg and pCMV-delta R8.9
vector [54]. Viral supernatants were collected 48–72 hours after
transfection and virus particles were concentrated using a
centrifugal filter device (Amicon Ultra-15, Millipore).
Mice, neuronal cultures, immunocytochemistry and
Western blotting
Synaptotagmin-1 knockout mice were obtained by interbreeding
of mice heterozygous for the synaptotagmin-1 mutation as described
[55]. All procedures to maintain and use these mice were
approved by the Institutional Animal Care and Use Committee
for Baylor College of Medicine and Affiliates.
Primary neuronal cultures were prepared as described [56].
Briefly, hippocampal neurons were prepared from postnatal day 0
mice and plated at the density of 300 cm
22 on WT astrocyte
microislands to obtain autaptic neurons for electrophysiology and
immunocytochemistry experiments. Neurons were plated at the
density of 10,000 cm
22 on confluent WT astrocytes for Western
blot experiments.
Immunocytochemistry was performed as described [56] with
modifications. Briefly, cultured neurons at day in vitro 10 were fixed
with 4% (w/v) paraformaldehyde for 30 minutes at room
temperature and the following primary antibodies (all from
Synaptic Systems) were used: rabbit anti-GFP (1:1000), guinea
pig anti-vesicular glutamate transporter-1 (1:1000), rabbit anti-
synaptophyin-1 (1:1000), and mouse anti-synaptotagmin-1 (clone
41.1, 1:200). Images were acquired on a Leica TCS SP5 laser-
scanning confocal microscope or a Zeiss 510 laser scanning
confocal microscope. The settings for laser power and detector
gain allowed the pixel intensities to remain within the dynamic
range. Images were acquired as z-stacks with 8-bit and 102461024
pixel resolution and processed using software NIH ImageJ 1.40 g
to create sum projections from the stacks.
Western blotting was performed as described [27] with mouse
anti-synaptotagmin-1 (clone 41.1, 1:12,000) and mouse anti-b-
Tubulin III (clone 3B11, 1:5,000, both antibodies from Synaptic
Systems).
Electrophysiology of cultured neurons
Whole-cell voltage clamp experiments were performed as
described [57] on autaptic hippocampal glutamatergic neurons
at room temperature (23–24uC). The extracellular solution
contained (mM): NaCl, 140; KCl, 2.4; HEPES, 10; glucose, 10;
CaCl2, 4 (for Figure 1A,B) or 2 (for Figures 1E,F and 3); MgCl2,4 ;
300 mOsm; pH 7.4. The patch pipette solution contained (mM):
KCl, 136; HEPES, 17.8; EGTA, 1; MgCl2, 0.6; ATP-Mg, 4;
GTP-Na, 0.3; Phosphocreatine, 12; Phosphocreatine kinase, 50U
ml
21; 300 mOsm; pH 7.4. Action potential-evoked EPSC, readily
releasable pool size, vesicular release probability, short-term
plasticity, and apparent Ca
2+ sensitivity of release were measured
as described [57]. Data were analyzed offline using AxoGraph X
(AxoGraph Scientific). Statistic significances were tested using
Student’s t-test, one-way analysis of variance, or two-way analysis
of variance.
Crystallization of the synaptotagmin-7 C2B Domain
The vector to express the mouse synaptotagmin-7 C2B
domain as a GST-fusion protein was described previously [58].
Bacterial expression of the synaptotagmin-7 C2B (residues 266–
403), cleavage from the GST moiety and purification were
performed as described previously for the synaptotagmin-1
C2B domain [59]. For crystallization, purified synaptotagmin-7
C2B domain was concentrated to 40 mg/ml in 25 mM
N a A c e t a t eb u f f e rp H6 . 2 ,5 0m MK C l ,2 0m MC a C l 2 ,a n d
1 mM TCEP. After concentration, a UV spectrum was
recorded to determine protein concentration and ensure that
the protein was not contaminated by DNA/RNA [59]. This
protein solution was used for crystallization trials. Large
multiple crystals were grown in 0.2M Li2SO4, 0.1M HEPES
pH 6.5, and 25% (w/v) PEG 3350. These crystals were
cryoprotected with 15% (v/v) ethylene glycol and flash-cooled
in liquid nitrogen.
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The crystallographic data were indexed and integrated using
HKL3000 [60]. The structure was phased using the molecular
replacement method with the synaptotagmin-1 C2B domain
structure (PDB accession code 1TJM) as a search model. 136 of
138 residues were automatically built into the electron density and
the sequence was assigned by the program ARP/warp [61], and
the remaining N- and C-terminal residues were manually modeled
into the electron density via the program COOT [62]. Refinement
was performed using multiple rounds of PHENIX [63] alternated
by model re-building in COOT. The final model for the
synaptotagmin-7 C2B domain contains residues 266––403, 4
Ca
2+ ions and 183 waters (final Rwork=16.0; Rfree=18.1; overall
B-factor=16.0). For data collection and refinement statistics, see
Table 1. In the final model, 95.9% of the residues are in the
favored regions of the Ramachandran map, and 4.1% of the
residues in the additionally allowed regions. Coordinates and
structure factors have been deposited in the Protein Data Bank
with accession code 3N5A.
Supporting Information
Figure S1 Delta HB mutant synaptotagmin-1 is expressed at
similar levels as WT synaptotagmin-1 and properly targets to
presynaptic terminals. synaptotagmin-1 KO neurons were infected
with lentiviruses expressing EGFP alone or Syt1 and EGFP
together. (A) Exemplary Western blot showing similar expression
levels of WT and delta HB Syt1. Neuron specific b-Tubulin III
serves as loading controls. (B) Exemplary confocal images showing
the presynaptic localization of WT and delta HB Syt1. Neurons
were immunostained with antibodies against the N-terminal
portion of the Syt1 C2A domain (magenta images), synaptophy-
sin-1 (green images), and EGFP (grey images). The merged images
show the presence of WT and delta HB Syt1 in the presynaptic
termini identified by synaptophysin-1. Scale bars: 10 mm.
Found at: doi:10.1371/journal.pone.0012544.s001 (1.84 MB
PDF)
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